About The Medical Condition EN1639A
Find the definition of the medical term EN1639A. EN1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN1639A
| EN1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Woman Rights ‐ The rights of women to equal status pertaining to social, economic,…
- Neurotheceomas ‐ A benign myxoma of cutaneous nerve sheath origin. Theke is from…
- Atrial Natriuretic Factor Receptors ‐ Cell surface proteins that bind atrial natriuretic factor with…
- Estrone, (+-)-Isomer ‐ A metabolite of estradiol but possessing less biological activity.…
- Television ‐ The transmission and reproduction of transient images of fixed…
- Abnormalities, Musculoskeletal ‐ Congenital structural abnormalities and deformities of the musculoskeletal…
- Juvenile Periodontitis ‐ Localized periodontitis in teenagers and young adults. The onset…
- Mammoplasties ‐ Surgical reconstruction of the breast including both augmentation…
- Gamma-Tocopherol ‐ A natural tocopherol with less antioxidant activity than ALPHA-TOCOPHEROL.…
- PGE1 ‐ A potent vasodilator agent that increases peripheral blood flow.…